Dr. Gene G. Finley, MD | Natrona ...

Dr. Gene G. Finley

Claim this profile

Allegheny General Hospital

Studies Colon Cancer
Studies Lung Cancer
12 reported clinical trials
41 drugs studied

Area of expertise

1Colon Cancer
Gene G. Finley has run 5 trials for Colon Cancer. Some of their research focus areas include:
Stage III
Stage IV
MLH1 positive
2Lung Cancer
Gene G. Finley has run 5 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.
Allegheny General Hospital
Image of trial facility.
Forbes Hospital

Clinical Trials Gene G. Finley is currently running

Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Radiation Therapy + Atezolizumab

for Small Cell Lung Cancer

This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radiation therapy in addition to atezolizumab may extend the time without extensive small cell lung cancer growing or spreading compared to atezolizumab alone.
Recruiting1 award Phase 2 & 311 criteria

More about Gene G. Finley

Clinical Trial Related10 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Gene G. Finley has experience with
  • Atezolizumab
  • Nivolumab
  • Relatlimab
  • Tucatinib
  • Trastuzumab
  • Durvalumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Gene G. Finley specialize in?
Is Gene G. Finley currently recruiting for clinical trials?
Are there any treatments that Gene G. Finley has studied deeply?
What is the best way to schedule an appointment with Gene G. Finley?
What is the office address of Gene G. Finley?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security